drugset / Trial / NCT06005558

Low Dose Versus High Dose Methylene Blue in Septic Patients

NCT06005558

Phase 2/3 Completed 90 enrolled National Cancer Institute, Egypt
RandomizedParallel-groupDouble-blindTreatment

Summary

The main aim of this study is to examine the various effects of continuous methylene blue infusion in septic cancer patients and to compare it with the traditional infusion of noradrenaline in such patients .

Timeline

Start
2023-08-01
Primary completion
2024-04-29
Completion
2024-05-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylene Blue Diagnostic / imaging agent 0.25 mg/kg Intravenous